Ziopharm Oncology reported $0 in Sales Revenues for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Amgen AMGN:US $ 6594M 356M
AstraZeneca AZN:LN 10771M 619M
Baxter International BAX:US $ 3746M 39M
Biogen BIIB:US $ 2589.1M 57.3M
Bristol Myers Squibb BMY:US $ 11887M 239M
Corcept Therapeutics CORT:US $ 103.39M 9.7M
Curis CRIS:US $ 2.39M 0.34M
Eleven Biotherapeutics EBIO:US $ 0M 20M
Gilead Sciences GILD:US $ 6260M 330M
GlaxoSmithKline GSK:LN 6929M 2851M
Immunogen IMGN:US $ 14.16M 23.92M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
Intrexon XON:US $ 2.91M 29.11M
IONIS PHARMACEUT IONS:US $ 141.92M 298.09M
Johnson & Johnson JNJ:US $ 24020M 594M
Karyopharm Therapeutics KPTI:US $ 39.68M 7.99M
Merk MRK:US $ 14593M 1308M
Novartis NOVN:VX SF 13085M 271M
Pfizer PFE:US $ 27742M 2081M
Ptc Therapeutics PTCT:US $ 165.53M 16.79M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Roche Holding ROG:VX 16.44B 474M
Sangamo Biosciences SGMO:US $ 29.38M 1.15M
Tg Therapeutics TGTX:US $ 0.59M 1.42M
Verastem VSTM:US $ 0M 2.6M
YTE INCY:US $ 911.4M 178.16M